Tvaster Genkalp

📍 Chennai, India🗓 Founded 2021👥 9 employees💰 Last funded Nov 2024
Medical and Diagnostic Laboratories🌐 tvastergen.com
Website LinkedIn
Tvaster Genkalp is a Molecular Diagnostics company, established in May 2021, specialising in Liquid Biopsy, offering blood based cancer diagnostic solutions. With innovative approach and commitment to quality, Tvaster has developed a groundbreaking screening test for Hepatocellular carcinoma (HCC) called Episcreen™ Liver. Episcreen™ Liver represents a major leap forward in the early detection of liver cancer (HCC). Rigorously validated through a study involving over 750 patients, this technology has demonstrated exceptional accuracy, far surpassing the current standard blood-based biomarker, AFP. The recent clinical study revealed that Episcreen™ Liver achieved an impressive sensitivity of 90%, in stark contrast to AFP’s 50%. Moreover, Episcreen™ Liver identified 92% of HCC cases missed by AFP, offering a potentially life-saving solution for countless individuals. Tvaster is dedicated to enhancing early cancer detection and improving patient outcomes through its state-of-the-art diagnostic solutions.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
India
1
Frequently asked questions
Who invested in Tvaster Genkalp?
Tvaster Genkalp has 1 investors on record on gritt.io, 1 mid-stage.
When did Tvaster Genkalp last raise funding?
The most recent investment in Tvaster Genkalp recorded on gritt.io was in November 2024.
When was Tvaster Genkalp founded?
Tvaster Genkalp was founded in 2021.
What industry is Tvaster Genkalp in?
Tvaster Genkalp operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is Tvaster Genkalp based?
Tvaster Genkalp is headquartered in Chennai, India.